NASDAQ:LMNL   Liminal BioSciences Inc
Liminal BioSciences Inc ., a clinical-stage biopharmaceutical company, focuses on discovery , development, and commercialization of novel small molecule drug candidates for the treatment of patients suffering from respiratory fibrotic diseases and other fibrotic or inflammatory diseases that have high unmet medical needs